Prostate Cancer
The changing landscape in the treatment of metastatic castration-resistant prostate cancer - Abstract
February 15, 2013
Diffusion-weighted magnetic resonance imaging for the evaluation of prostate cancer: Optimal b value at 3T - Abstract
February 15, 2013
Extended salvage pelvic and retroperitoneal lymph node dissection due to prostate cancer relapse - Abstract
February 15, 2013
GU Cancers Symposium 2013 - Clinical trial design strategies in the post-abiraterone/enzalutamide setting, by Charles J. Ryan, MD, UCSF - Session Highlights
February 15, 2013
Development and evaluation of an actuated MRI-compatible robotic system for MRI-guided prostate intervention - Abstract
February 15, 2013
Primary care physicians' use of an informed decision-making process for prostate cancer screening - Abstract
February 15, 2013
Androgen deprivation therapy toxicity and management for men receiving radiation therapy - Abstract
February 15, 2013
Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer - Abstract
February 15, 2013
Novel therapies for the treatment of advanced prostate cancer - Abstract
February 15, 2013
GU Cancers Symposium 2013 - Additional Noteworthy Research to be Presented at the 2013 Genitourinary Cancers Symposium
February 14, 2013
GU Cancers Symposium 2013 - Active Surveillance- Intelligent PSA Testing
February 14, 2013
GU Cancers Symposium 2013 - Improving active surveillance: The emerging role of biomarkers
February 14, 2013
GU Cancers Symposium 2013 - The pathology perspective on available tools for active surveillance
February 14, 2013